OVID THERAPEUTICS INC. - COMMON STOCK

0.7341

24-January-25 16:45:00

15 minutes delayed

Stocks

+0.0243

+3.42%

Today's range

0.7135 - 0.7823

ISIN

N/A

Source

NASDAQ

Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

13 May 2021 16:05:01 By Nasdaq GlobeNewswire
Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

12 May 2021 08:00:02 By Nasdaq GlobeNewswire
Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board

20 Apr 2021 08:00:02 By Nasdaq GlobeNewswire
OVID Provides Update on OV101 Program and the Prioritization of its Resources

19 Apr 2021 08:00:01 By Nasdaq GlobeNewswire
Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat

30 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021

15 Mar 2021 08:00:02 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.